16295 studies found for:    "Vascular Diseases"
Show Display Options
Rank Status Study
21 Completed Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)
Conditions: PCV;   Polypoidal Choroidal Vasculopathy
Interventions: Drug: high-dose ranibizumab;   Drug: ranibizumab
22 Completed Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)
Condition: Polypoidal Choroidal Vasculopathy
Interventions: Drug: fosbretabulin;   Drug: Saline
23 Completed
Has Results
Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Interventions: Drug: Verteporfin Photodynamic Therapy;   Drug: Ranibizumab
24 Completed Open Label Clinical Study to Assess the Clinical Safety of a New Compression Device in Subjects With Peripheral Arterial Vascular Disease
Condition: Peripheral Arterial Vascular Disease
Intervention: Procedure: A new treatment approach is to have an effective working pressure combined with a low resting pressure.
25 Completed Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular Disease
Condition: PERIPHERAL VASCULAR DISEASE
Interventions: Procedure: Conventional angioplasty balloon;   Procedure: cryoplasty balloon
26 Enrolling by invitation Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention: Drug: Ramipril or placebo
27 Completed Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV)
Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: ranibizumab intravitreal injection
28 Completed
Has Results
Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients
Condition: Vascular Diseases
Interventions: Drug: Gadobutrol (Gadavist, Gadovist, BAY86-4875);   Drug: Gadopentate dimeglumine (Magnevist, BAY86-4882)
29 Active, not recruiting A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention:
30 Completed Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography
Condition: Cardiac Allograft Vasculopathy
Intervention:
31 Unknown  Warfarin and Antiplatelet Vascular Evaluation
Conditions: Peripheral Vascular Diseases;   Cardiovascular Diseases
Intervention: Drug: Warfarin
32 Terminated Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Condition: Cardiac Allograft Vasculopathy
Interventions: Biological: Rituximab induction/conventional immunosuppression (tacrolimus, MMF, and steroid taper);   Drug: Rituximab placebo/conventional immunosuppression (tacrolimus, MMF, and steroid taper)
33 Recruiting Open-label Pilot Study to Assess the Use of Magic Foot™ in the Improvment of Parameters in Subject With Foot Symptoms
Conditions: Diabetes;   Peripheral Vascular Disease
Intervention: Device: Magic Foot™
34 Terminated Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia
Condition: Peripheral Vascular Disease
Interventions: Drug: Hemoglobin glutamer 250 - bovine;   Drug: 6% Hydroxyethylstarch
35 Recruiting Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy
Conditions: Exudative Age-related Macular Degeneration;   Polypoidal Choroidal Vasculopathy
Intervention: Drug: aflibercept
36 Recruiting Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation
Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: Intravitreal aflibercept injection 2.0mg
37 Active, not recruiting Identification of Non Invasive Biomarkers of Immune Endothelial Injury and Repair Associated With Cardiac Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention: Biological: blood samples
38 Unknown  IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD
Conditions: Polypoidal Chorodial Vasculopathy;   Age Related Macular Degeneration
Intervention: Radiation: Iray
39 Recruiting Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial)
Condition: Neovascular Polypoidal Choroidal Vasculopathy
Interventions: Drug: Rescue Intravitreal Aflibercept Injection;   Procedure: Rescue Therapy with PDT, Laser or Intravitreal Steroids
40 Unknown  A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV)
Condition: Cardiac Allograft Vasculopathy
Intervention: Drug: Thymoglobulin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years